U.S. STOCKS ON THE MOVE-Tesla, Nvidia, Rivian
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nvidia, Rivian July 7 (Reuters) - Nasdaq futures dropped on Tuesday following declines in chip stocks as investors reassessed the sustainability of the AI-driven rally despite strong results from Samsung, while SpaceX shares dipped ahead of their Nasdaq-100 debut. .N
** Tesla Inc TSLA.O:
BUZZ - RBC lifts Tesla price target, cites potential SpaceX deal nL6N4390FS
** Space Exploration Technologies Corp SPCX.O:
BUZZ - Down ahead of Nasdaq 100 inclusion, brokerages start coverage nL4N4390M7
** Rivian Automotive Inc RIVN.O:
BUZZ - Falls after announcing stock offering nL6N4390KK
** Sandisk Corp SNDK.O:
** Seagate Technology Holdings PLC STX.O:
** Western Digital Corp WDC.O:
BUZZ - US chip stocks falls after Samsung results spark fresh AI jitters nL4N4390P9
** Cloudflare Inc NET.N:
BUZZ - Gains; Scotiabank raises to 'sector outperform' nL6N4390LK
** Crinetics Pharmaceuticals Inc CRNX.O:
BUZZ - Soars as Vertex agrees to $10 billion buyout nL4N4390T7
** Agios Pharmaceuticals Inc AGIO.O:
BUZZ - Rises as FDA grants priority review to sickle cell disease drug nL4N4390VL
** Compass Pathways PLC CMPS.O:
BUZZ - Rises on positive late-stage trial data for depression drug nL4N4390VB
** Nvidia Corp NVDA.O:
BUZZ - Falls after report DeepSeek developing its own AI chip nL4N4390V2
(Compiled by Rajarshi Roy and Prakhar Srivastava in Bengaluru)
Recent news on Agios Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Agios Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Agios Q2 revenue jumps on US commercial launch of AQVESME
Brief: Agios Pharmaceuticals Q2 Product Revenue USD 44.745 Million Vs. IBES Estimate USD 25.5 Million